PREDAIR FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Predair Forte, and what generic alternatives are available?
Predair Forte is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in PREDAIR FORTE is prednisolone sodium phosphate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Predair Forte
A generic version of PREDAIR FORTE was approved as prednisolone sodium phosphate by BAUSCH AND LOMB INC on July 29th, 1994.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PREDAIR FORTE?
- What are the global sales for PREDAIR FORTE?
- What is Average Wholesale Price for PREDAIR FORTE?
Summary for PREDAIR FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| Patent Applications: | 7,323 |
| DailyMed Link: | PREDAIR FORTE at DailyMed |
US Patents and Regulatory Information for PREDAIR FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | PREDAIR FORTE | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 088165-001 | Mar 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
